PBM
Psyence Biomedical Ltd.NASDAQHealthcare$2.53+2.43%ClosedMarket Cap: $48,118
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.21
P/S
0.00
EV/EBITDA
-5.94
DCF Value
$7.60
FCF Yield
-7781.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-47.6%
ROA
13.8%
ROIC
-54.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | -Infinity% | $-1.5M | $-753.3K | $-0.51 | — |
| FY 2024 | $0.00 | -Infinity% | $-3.7M | $1.0M | $1.78 | — |
| Q2 2024 | $0.00 | -Infinity% | $-1.2M | $141.5K | $5.50 | — |
| FY 2023 | $0.00 | -Infinity% | $-2.8M | $-51.2M | $-7.85 | — |
| Q3 2023 | $0.00 | NaN% | $-632.1K | $-24.8M | $-1.85 | — |
| Q2 2023 | $0.00 | NaN% | $-754.4K | $-647.8K | $-0.08 | — |
| Q1 2023 | $0.00 | NaN% | $-512.1K | $-62.8K | $-0.01 | — |
| Q4 2022 | $0.00 | NaN% | $-1.0M | $-24.5K | $-0.00 | — |
| FY 2022 | $0.00 | NaN% | $-1.3M | $8.0M | $-0.64 | — |
| Q3 2022 | $0.00 | NaN% | $-510.9K | $2.3M | $0.07 | — |
| Q2 2022 | $0.00 | NaN% | $-244.0K | $3.7M | $0.03 | — |
| Q1 2022 | $0.00 | NaN% | $-293.0K | $2.0M | $0.07 | — |